Related Experiment Video
Updated: May 27, 2026

A Modified Surgical Technique for Kidney Transplantation in Mice
Published on: July 22, 2022
[Kidney transplantation and infection in childhood]
Bruno Ranchin1, Laure Hees, Didier Stamm
1Service de Néphrologie Pédiatrique, Hôpital Femme Mère Enfant, Hospices Civils de Lyon et Université de Lyon. bruno.ranchin@chu-lyon.fr
Insights
Pediatric transplant recipients face higher infectious risks due to lower immunization rates. Comprehensive vaccination strategies, including Epstein Barr Virus (EBV) immunization, are crucial for managing post-transplant complications.
Area of Science:
- Pediatric Infectious Diseases
- Transplantation Immunology
- Vaccinology
Context:
- Children undergoing transplantation have unique immunological profiles compared to adults.
- Pediatric transplant recipients are more susceptible to a wider range of pathogens, including viruses and bacteria like pneumococcus.
- Standard immunization schedules may not fully address the specific needs of immunocompromised pediatric populations.
Purpose:
- To highlight the heightened infectious risks in pediatric transplant recipients.
- To emphasize the critical role of timely and comprehensive immunization in this vulnerable group.
- To underscore the importance of evaluating immunization response through serological monitoring.
Summary:
- Pediatric transplant patients exhibit increased susceptibility to infections due to incomplete childhood immunizations and greater exposure to infectious agents.
- Transplantation teams must prioritize adherence to standard immunization schedules and administer additional recommended vaccines to pediatric recipients, their families, and caregivers.
- Pre- and post-transplant serological monitoring is essential to assess immune response, particularly for vaccines like Epstein Barr Virus (EBV), to mitigate risks such as post-transplant lymphoproliferative disorder.
Impact:
- Optimized immunization protocols can significantly reduce infectious complications in pediatric transplant recipients.
- Proactive vaccination strategies, including EBV-specific measures, can lower the incidence of serious post-transplant sequelae like lymphoproliferative disorders.
- Improved long-term outcomes and quality of life for pediatric transplant survivors through enhanced infectious disease prevention.
Abstract:
Infectious risk is more important in the transplanted child than in adult because children are less often immunised against pathogens ant more exposed than adults to numerous infectious agents (virus but also bacteria including pneumococcus). The application of the standard immunisation schedule must be a permanent concern of transplantation (Tx) teams. Some vaccines that are not planned in the standard immunization schedule are particularly advised for the child and his family circle, as well as for caregivers. Immunisation response must be evaluated by a serological follow-up before Tx, in particular during the pre-Tx diagnostic work-up, then regularly after Tx. The more frequent absence of immunisation against Epstein Barr Virus (EBV) in children explains the increased frequency of post-transplant lymphoproliferative disorder at the pediatric age.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Chronic Kidney Disease I: Introduction

